Skip to Main Content

Paper Details

Economic and Clinical Burden of Relapsed and/or Refractory Active Treatment Episodes in Patients with Acute Myeloid Leukemia (AML) in the USA: A Retrospective Analysis of a Commercial Payer Database.
Adv Ther
18
2019
Author NameAffiliation
Bruno C MedeirosStanford University School of Medicine
  • 1 - 1

Datasets

Release 1.2